NIBR-17 is primarily used as a potent and selective inhibitor in biochemical research, particularly in studies involving kinase signaling pathways. It has been employed to probe the function of specific kinases involved in cell proliferation and survival, making it a valuable tool in oncology-related research. Due to its high selectivity, NIBR-17 enables scientists to dissect complex cellular mechanisms with minimal off-target effects. It is commonly utilized in in vitro assays and cell-based models to evaluate therapeutic strategies for cancers, especially those driven by dysregulated kinase activity. Its application supports the development and validation of targeted therapies, aiding in the identification of potential drug candidates and biomarkers.